Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice. 2017

Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
Department of Forestry, National Chung Hsing University, Taichung 402, Taiwan.

Some members of Rhododendron genus are traditionally used as medicinal plants for arthritis, acute and chronic bronchitis, asthma, pain, inflammation, rheumatism, hypertension and metabolic diseases. To the best of our knowledge, there is no report on the protective effects of R. oldhamii leaf extract on non-alcoholic fatty liver disease (NAFLD) in vivo and in vitro. In this study, the effects of R. oldhamii leaf extract on inhibiting the free fatty acid (FFA)-induced accumulation of fat in HepG2 cells and on improving fatty liver syndrome in mice with high fat diet (HFD)-induced NAFLD were investigated. For the in vitro assay, HepG2 cells were treated with FFAs (oleate/palmitate = 2:1) with or without treatment with R. oldhamii leaf ethyl acetate (EtOAc) fraction to observe lipid accumulation using Nile red and oil red O stains. For the in vivo assay, C57BL/6 mice were randomly assigned to three groups (n = 5), including the normal diet group, the HFD group and the HFD+EtOAc group. After 11 weeks, body weight, serum biochemical indices and the mRNA expressions of the liver tissue, as well as the outward appearance, weight and histopathological analysis of liver and adipose tissues were evaluated. Among the fractions derived from R. oldhamii leaf, the EtOAc fraction exhibited a strong fat-accumulation inhibitory activity. Following reverse-phase high-performance liquid chromatography (HPLC), four specific phytochemicals, including (2R, 3R)-astilbin (AS), hyposide (HY), guaijaverin (GU) and quercitrin (QU), were isolated and identified from the EtOAc fraction of R. oldhamii leaf extract. Among them, AS and HY showed excellent fat-accumulation inhibitory activity. Thus, the EtOAc fraction of R. oldhamii leaf and its derived phytochemicals have great potential in preventing FFA-induced fat accumulation. In addition, the EtOAc fraction of R. oldhamii leaf significantly improved fatty liver syndrome and reduced total cholesterol (TC) and triglyceride (TG) in HFD-induced NAFLD mice at a dosage of 200 mg/kg BW. These results demonstrated that the methanolic extracts from R. oldhamii leaf have excellent inhibitory activities against fat accumulation and anti-NAFLD activities and thus have great potential as a natural health product.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D050155 Lipogenesis De novo fat synthesis in the body. This includes the synthetic processes of FATTY ACIDS and subsequent TRIGLYCERIDES in the LIVER and the ADIPOSE TISSUE. Lipogenesis is regulated by numerous factors, including nutritional, hormonal, and genetic elements. Lipogeneses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
September 2014, International journal of obesity (2005),
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
March 2019, Nutrients,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
January 2019, Biochemical and biophysical research communications,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
May 2018, Lipids,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
August 2022, Molecules (Basel, Switzerland),
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
December 2020, Food & function,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
March 2005, American journal of physiology. Regulatory, integrative and comparative physiology,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
January 2018, Frontiers in pharmacology,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
January 2021, Food & function,
Ya-Ling Liu, and Lei-Chen Lin, and Yu-Tang Tung, and Shang-Tse Ho, and Yao-Li Chen, and Chi-Chen Lin, and Jyh-Horng Wu
September 2020, Molecular medicine reports,
Copied contents to your clipboard!